Kamada (KMDA) Non Operating Income (2017 - 2026)
Kamada (KMDA) reported Non Operating Income of $1.6 million for Q1 2026, up 32.15% on a YoY basis from $1.2 million in Q1 2025, and up 232.04% quarter-over-quarter from -$1.2 million in Q4 2025.
Kamada (KMDA) Non Operating Income (2017 - 2026) Analysis & Trends
Kamada has reported Non Operating Income for 9 years, with the latest figure at $1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 32.15% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (down 83.71% YoY), and the FY2025 full-year result was $2.8 million, down 58.82% from the prior year.
- Non Operating Income for Q1 2026 stood at $1.6 million, up from -$1.2 million in the prior quarter.
- The five-year high for Non Operating Income was $6.7 million in Q4 2024, with the low at -$1.2 million in Q4 2025.
- Historically, Non Operating Income has averaged $1.1 million across 4 years, with a median of $11000.0 in 2024.
- Annual changes were most pronounced in 2024 — Non Operating Income jumped 670700.0% — and 2025, when it plunged 227.27%.
- Kamada's Non Operating Income stood at -$1000.0 in 2023, then jumped by 670700.0% to $6.7 million in 2024, then tumbled by 117.64% to -$1.2 million in 2025, then soared by 232.04% to $1.6 million in 2026.
- The last three Non Operating Income figures came in at $1.6 million (Q1 2026), -$1.2 million (Q4 2025), and -$14000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.56 Mn |
| Dec 31, 2025 | -1.18 Mn |
| Sep 30, 2025 | -14,000.00 |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 6.71 Mn |
| Sep 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | -157,000.00 |
| Dec 31, 2021 | 1.36 Mn |
| Dec 31, 2020 | 739,000.00 |
| Mar 31, 2020 | -774,000.00 |
| Dec 31, 2019 | -33,000.00 |
| Sep 30, 2019 | -340,000.00 |
| Mar 31, 2019 | 156,000.00 |
| Dec 31, 2018 | -417,000.00 |
| Sep 30, 2018 | -133,000.00 |
| Dec 31, 2017 | -122,000.00 |